DIEP Flap Perfusion Evaluated by DIRT and ICG-FA.

Sponsor
University Hospital of North Norway (Other)
Overall Status
Unknown status
CT.gov ID
NCT04115995
Collaborator
UiT The Arctic University of Norway (Other)
30
1
11.5
2.6

Study Details

Study Description

Brief Summary

Patients selected for DIEP breast reconstruction were examined with preoperative CTA, Doppler Ultrasound, dynamic infrared thermography (DIRT) and Indocyanin green fluorescent angiography (ICG-FA) for perforator mapping. DIRT and ICG-FA were used to evaluate perfusion of selected perforators. Following anastomoses for the DIEP flap to internal mammary vessels , patency of the anastomosis was evaluated with DIRT and ICG-FA. Recorded images from all the modules were compared.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Dynamic infrared thermography (DIRT) and indocyanine green fluorescence angiography (ICG-FA)

Detailed Description

Introduction:

'The primary aim of our study is to compare invasive and non-invasive techniques to select a dominant perforator when harvesting a DIEP-flap for autologous breast reconstruction.

The secondary aim is to compare Dynamic Infrared Thermography (DIRT) and Laser Fluorescence Angiography (LFA) of Indocyanine green (ICG) in order to see whether they could be useful in the early detection of insufficient perfusion following the microvascular anastomotic procedure in DIEP flaps.

Material and Method:

Patients selected for breast reconstruction with autologous tissue were examined with preoperative CTA and a handheld Doppler Ultrasound for perforator mapping. Thereafter visual images from same area was obtained with dynamic infraredeed thermography (DIRT) and Indocyanin green fluorescent angiography (ICG-FA) before and after dissection of the skin flap with preserved medial and lateral DIEP perforators. Reconstructed breasts with hemi-DIEP-flaps were intraoperatively evaluated with DIRT and LFA immediately after the completion and opening of the microvascular anastomosis.The recorded images from the different techniques were assesses in relation to clinical outcome.

.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Perforator Mapping and Anastomosis Patency Evaluated by Dynamic Fluorescence Video Angiography of Indocyanine Green and Infrared Thermography.
Actual Study Start Date :
Jan 16, 2019
Anticipated Primary Completion Date :
Dec 24, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Outcome Measures

Primary Outcome Measures

  1. Assessment of quality and location of perforating blood vessels with dynamic infrared thermography and indocyanine green angiography in autologous breast reconstruction: A comparative imaging study. [2 year]

    Pre-and intraoperative use of two different imaging technologies to assess quality and location of perforating blood vessels in autologous breast reconstruction. In this study we will compare images obtained using a non-invasive imaging technique, dynamic infrared thermography and an invasive imaging technique, laser fluorescence angiography of indocyanine green.

  2. Quality of microvascular anastomosis by measuring perfusion through the anastomosis using dynamic infrared thermography and laser fluorescence angiography of indocyanine green. [2 years]

    The microvascular anastomosis provides blood supply to tissue used in breast reconstruction. The blood flow through the microvascular anastomosis can be monitored by use of different imaging techniques. In this study, perfusion images obtained by non-invasive dynamic infrared thermography and invasive fluorescence angiography of indocyanine green will be compared.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Post mastectomy.

  • Previously breast cancer patent treated with radiation therapy.

  • Breast implant reconstruction is not possible or undesired.

  • Healthy patient with moderate amounts of abdominal skin laxity.

  • Patient who requires a minimal to moderate volume breast reconstruction.

  • The patient willing to undergo the long, complex procedure and prolonged postoperative recovery.

  • The patient willing to accept an abdominal scar and a potential for donor site morbidities.

  • Patients operated with prophylactic salpingo-oophorectomy due to BRCA gene mutation.

Exclusion Criteria:
  • Pregnancy and lactation.

  • Patents below the age of 18 year.

  • Renal failure or hepatic failure.

  • Previous allergic reactions to ICG and iodide.

  • Abdominal donor site that cannot be closed primarily.

  • Previous TRAM flap or abdominoplasty.

  • Significant medical comorbidities that make the patient a poor surgical candidate.

  • Sigarette smoking or snuff.

  • Obesity / BMI > 30.

  • Previous abdominal suction-assisted lipectomy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Univesity Hospital of North Norway Tromsø Norway 9038

Sponsors and Collaborators

  • University Hospital of North Norway
  • UiT The Arctic University of Norway

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital of North Norway
ClinicalTrials.gov Identifier:
NCT04115995
Other Study ID Numbers:
  • 22017/1641
First Posted:
Oct 4, 2019
Last Update Posted:
Oct 4, 2019
Last Verified:
Dec 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital of North Norway

Study Results

No Results Posted as of Oct 4, 2019